Latest News and Press Releases
Want to stay updated on the latest news?
-
Company announcement – No. 55 / 2021 Zealand Pharma to Participate in Goldman Sachs 11th Annual Biotech Symposium Copenhagen, DK and Boston, MA, U.S. August 31, 2021 – Zealand Pharma A/S...
-
Company announcement – No. 54 / 2021 Total number of shares and voting rights in Zealand Pharma at August 31, 2021 Copenhagen, DK and Boston, MA, August 31, 2021 – Zealand Pharma A/S (“Zealand”)...
-
Company announcement – No. 53 / 2021 Zealand Pharma increases its share capital as a consequence of exercise of employee warrants Copenhagen, DK and Boston, MA, U.S. August 20, 2021 –...
-
Company announcement – No. 52 / 2021 Zealand Pharma Announces First Patient Dosed in EASE-SBS 4 Phase 3b Trial Assessing Glepaglutide in Patients with Short Bowel Syndrome The EASE-SBS 4 Phase 3b...
-
Company announcement No. 51 / 2021 Employee Elected Director to step down from the board of Zealand Pharma A/S Copenhagen, DK, August 13, 2021 – Zealand Pharma A/S (“Zealand”) (Nasdaq: ZEAL)...
-
Company annoucement - No. 50 / 2021 Interim report for H1 2021 Zealand Pharma Launches ZEGALOGUE® (dasiglucagon) Injection and Advances Pipeline Programs Across Multiple Therapeutic Areas ...
-
Company announcement – No. 49 / 2021 Zealand Pharma Hosts Conference Call on August 12 at 4 pm CET (10am ET) to Present Second Quarter Results for 2021 Copenhagen, DK and Boston,...
-
Company announcement – No. 47 / 2021 Zealand Pharma A/S – Final Transactions Under Share Repurchase Program Copenhagen, DK, 27 July 2021 - On June 29, 2021, Zealand Pharma A/S ("Zealand")...
-
Company announcement – No. 47 / 2021 Zealand Pharma A/S – Transaction Under Share Repurchase Program Copenhagen, DK and Boston, MA, 20 July 2021 - On June 29, 2021, Zealand Pharma A/S...
-
Company announcement – No. 46 / 2021 Zealand Pharma A/S – Transaction Under Share Repurchase Program Copenhagen 13 July 2021 - On June 29, 2021, Zealand Pharma A/S ("Zealand")...